Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research
Kapa65 / Pixabay

Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research

According to a story from Parkinson's News Today, a recent analysis of Parkinson's disease research showed that scientists would benefit from relying less on animal models and instead should focus…

Continue Reading Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research

Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated

Two Phase 2 clinical trials called ‘Elektra’ and ‘Arcade’ have been initiated. They will investigate the drug OV935/TAK-935 as a potential treatment for paediatric patients with rare epilepsies. For more…

Continue Reading Two Phase 2 Clinical Studies of a Drug for Rare Epilepsies Have Been Initiated
New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
blickpixel / Pixabay

New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy

Researchers at the University of Utah are working on developing computational tools that can be used to help identify the genetic changes underlying early infantile epileptic encephalopathy. For more detailed…

Continue Reading New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease
Philippedelavie / Pixabay

Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease

Avrobio has received no objection from Health Canada for their clinical trial application for their Phase 1/2 study of an investigational gene therapy for Gaucher disease. Following this news, Avrobio…

Continue Reading Avrobio Plans to Go Ahead with a Phase 1/2 Study of a Gene Therapy in Gaucher Disease
Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
geralt / Pixabay

Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements

Shriners Hospitals for Children® has announced their motion analysis centre consortium. The hospital’s Motion Analysis Centre is used to evaluate the movements and gait of children and teenagers. To read about…

Continue Reading Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared
Free-Photos / Pixabay

Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared

Nightstar Therapeutics has released preliminary data from a Phase 1/2 study of an experimental gene therapy designed to treat X-linked retinitis pigmentosa. For more detailed information you can view the…

Continue Reading Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared

Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders

A study carried out by researchers from Harvard Medical School and Brigham and Women’s Hospital has explored the link between dopamine neurones, Parkinson’s disease, and psychiatric disorders. To read about…

Continue Reading Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders
A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
Alexas_Fotos / Pixabay

A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria

According to a story from Medical Xpress, an international group of scientists from the US, France, and Spain may have discovered that an antifungal agent commonly used to treat skin…

Continue Reading A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria